We're taking on cancer.

Join the movement.

Watch video

reflexion x1. the time is now.

Be among the first to join the journey to BgRT.

Learn More

reflexion machine

Turning cancer on
itself > Finally

RefleXion’s biology-guided radiotherapy (BgRT) allows us to detect and respond to signals emitted from the cancer itself, and for the first time, use them to guide immediate treatment.

Real-Time Guidance

Cancer is talking.
We’re listening.

When PET radiotracers are introduced into the body, cancer absorbs them and acts as a biological beacon, which our machine can use to track and treat cancer in real time.

Learn More About Emissions

Targeting Cancer

Good news for organs. Bad news for tumors.

Our technology aims to deliver high doses of radiation to tumors, even while in motion, for greater impact to the tumor with less dose to the surrounding tissue.

Learn About Targeting

Metastatic Disease

A world where stage is just a number.

Most patients with stage four cancer are not considered candidates for definitive radiotherapy due to the challenge of treating multiple tumors. Our breakthrough technology is challenging that and aims to treat multiple tumors, in parallel, during a single session. 

Discover the Potential

Combination Treatment

Come at cancer from every angle.

Treatment isn’t a one-size-fits-all situation. For many patients, the best treatment plan is a combination of multiple therapies. RefleXion will work together with chemotherapy, immunotherapy and targeted drugs for potentially better outcomes.

Learn About Treatment

Learn more about RefleXion

RefleXion BGRT

By combining PET-CT and radiotherapy, we're able to find and treat cancer using its own emissions.

Clinicians

Discover RefleXion Therapy.

Cancer Centers

See how RefleXion Therapy can play a role
in your cancer program.

Make every day count

See Available Positions

Latest

Press Releases

RefleXion and Telix Pharmaceuticals Announce Strategic Collaboration for Treatment of High-Risk Cancers

HAYWARD, Calif., and MELBOURNE, Australia, July 8, 2020 – RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy* (BgRT) as a new modality for treating all stages of cancer, and Telix Pharmaceuticals Limited (ASX: TLX), a radiopharmaceutical company developing molecularly-targeted radiation (MTR) products, today announced a strategic collaboration to investigate the clinical utility of combining […]

View All Press chevron right

Blog

Reflexion X1 arcs blog

RefleXion Combination Therapy: Crossing the Divide with Biology-guided Radiotherapy to Treat the Untreatable

RefleXion Medical Inc. and Merck & Co., Inc., recently announced their clinical collaboration to evaluate the safety and efficacy of KEYTRUDA® with RefleXion’s biology-guided radiotherapy (BgRT) for treating late-stage cancers. “We believe this exciting collaboration is among one of the first of its kind between an external-beam radiotherapy (EBRT) and a pharmaceutical company,” said Thorsten […]

View All Blog Posts chevron right

Feedback
and
Inquiries.

Let us tell you more.

Contact Us

Sign up for our
latest news and information.

Stay up to date.

Sign Up